If I’d Invested in Cineplex at the Start of 2022, Here’s What I’d Have Now

Canadian investors who snatched up Cineplex Inc. (TSX:CGX) stock in early 2022 will have taken a loss in the year-to-date period.

| More on:
movies, theatre, popcorn

Image source: Getty Images

Cineplex (TSX:CGX) is a Toronto-based entertainment and media company. Most Canadians should recognize Cineplex as the top cinema operator in the country. That role has afforded the company some terrific advantages in previous years. However, it faced a generational challenge in the form of the COVID-19 pandemic in 2020. Fortunately, the company was able to survive.

Today, I want to explore how an investment in this top cinema stock would have performed over the course of this year.

If we’d snatched up Cineplex at the start of 2022…

Cineplex was able to recoup some of its sharp 2020 losses in 2021. It entered the previous year with its stock in single digits and would climb passed the $16/share mark by the early summer. In late 2021, the company had returned to nearly full operation and a crowded streaming sector had breathed new hope into the old guard. Investors who wanted to bet on a continued comeback for the movie theatre industry could talk themselves into Cineplex stock in the beginning of 2022.

Shares of this stock closed at $13.61 on December 31, 2021. For our hypothetical, let us say that we purchased 150 shares of Cineplex for a purchase price of $2,041.50 as markets opened on January 3, 2022.

This year has not been worth celebrating for most investors. Unfortunately, that would still be the case for anyone who jumped on this top cinema stock to kick off the New Year. Shares of Cineplex have plunged 31% in 2022 as of close on September 30, 2022. It was last priced at $9.10 per share. This means that our original 150-share investment would be worth $1,365 ahead of the first trading session in October. That is a loss of $676.50.

Could we hope to claw back to our original investment before the end of 2022? Or should we cut our losses and lick our wounds in this volatile market?

How does the company and the broader industry look right now?

Investors can expect to see its third-quarter fiscal 2022 earnings in the first half of November. In the second quarter of 2022, the company posted total revenue growth of 438% to $349 million. Meanwhile, theatre attendance soared 866% to 11.1 million. Box office revenues per patron and concession revenues per patron increased 12% in the year-over-year period.

In the year-to-date period, Cineplex delivered total revenue growth of 444% to $578 million. Theatre attendance rose to 17.8 million over 1.6 million in the first six months of fiscal 2021. That said, Cineplex had its doors closed for most of the first half of fiscal 2021.

The company provided August 2022 box office results on September 9. It posted box office revenues of $36 million this past August. That represented only 64% of box office revenues compared to the same month in 2019. However, Cineplex did deliver a strong July that saw revenues of $66 million. That represented 85% of the revenue total in July 2019. Investors should be pleased with that number considering what the company has gone through in the early part of this decade.

Cineplex: Here’s what I’d do with the stock right now

The movie theatre industry has not quite returned to pre-pandemic form, but it has bounced back nicely in a relatively short period. Cineplex stock is trading in favourable value territory relative to its industry peers. Meanwhile, it remains on track for solid revenue growth going forward. This is a risky stock that is also undervalued at the time of this writing. I’d look to hold on to our original investment ahead of what is typically a very profitable Halloween movie-going season.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ambrose O'Callaghan has no position in any of the stocks mentioned. The Motley Fool recommends CINEPLEX INC. The Motley Fool has a disclosure policy.

More on Investing

Senior Couple Walking With Pet Bulldog In Countryside
Dividend Stocks

CPP Insights: The Average Benefit at Age 60 in 2024

The average CPP benefit at age 60 in average is low, but claiming early has many advantages with the right…

Read more »

edit Sale sign, value, discount
Investing

2 Bargains I’d Buy as They Dip Toward 52-Week Lows

Spin Master (TSX:TOY) stock and another underrated Canadian play could surge again as they look to reverse course.

Read more »

thinking
Dividend Stocks

Why Did goeasy Stock Jump 6% This Week?

The spring budget came in from our federal government, and goeasy stock (TSX:GSY) investors were incredibly pleased by the results.

Read more »

woman analyze data
Dividend Stocks

My Top 5 Dividend Stocks for Passive-Income Investors to Buy in April 2024

These five TSX dividend stocks can help you create a passive stream of dividend income for life. Let's see why.

Read more »

investment research
Stocks for Beginners

New Investors: 5 Top Canadian Stocks for 2024

Here are five Canadian stocks that might be ideal for a beginner investment portfolio.

Read more »

Pipeline
Energy Stocks

Here Is Why Enbridge Is a No-Brainer Dividend Stock

For investors looking for a no-brainer dividend stock worth holding for the long term, here's why Enbridge (TSX:ENB) should be…

Read more »

Dots over the earth connecting the world
Tech Stocks

Hot Takeaway: Concentration in 1 Stock Can Be Just Fine

Concentration in one stock can be alright under the right circumstances, and far better than buying a bunch of poor-performing…

Read more »

grow money, wealth build
Bank Stocks

TD Bank Stock Got Upgraded, and It’s a Good Time to Load Up

TD Bank (TSX:TD) stock is getting too cheap, even for analysts at the competing banks!

Read more »